A Prospective, Observational Trial of Transvaginal Uterine Suspension With the New Minimally Invasive Uterine Suspension

Status: Recruiting
Location: See location...
Intervention Type: Procedure
Study Type: Observational
SUMMARY

Transvaginal or transabdominal surgeries are current choices of uterus-preserving surgeries for pelvic organ prolapse. Laparoscopic lateral uterine suspension, a modified surgical approach of uterine suspension from bilateral abdominal wall fascia, performed with expected safety and simplicity of surgery besides advantages including small wound incision and fast recovery in laparoscopic surgeries. This trial aim to discuss the therapeutic efficacy, long term safety, and adverse events of laparoscopic lateral uterine suspension and compare with the conventional transvaginal sacrospinous ligament fixation with native tissue repair.

Eligibility
Participation Requirements
Sex: Female
Minimum Age: 21
Healthy Volunteers: f
View:

• older than 21 years old.

• uterine prolapse stage 2 at least, defined by C point distal to -1cm by POP-Q system.

• patients willing to receive a uterine-preserving surgery for pelvic organ prolapse, and is suitable for anesthesia after evaluation.

• patients who had or had not received conservative treatments for pelvic organ prolapse.

• patients able and willing to finish the questionnaire evaluation.

Locations
Other Locations
Taiwan
National Cheng Kung University Hospital
RECRUITING
Tainan City
Contact Information
Primary
Yu Fang Huang, MD
yufangh@ncku.edu.tw
886-6-2353535
Time Frame
Start Date: 2022-07-26
Estimated Completion Date: 2029-12-31
Participants
Target number of participants: 90
Treatments
Laparoscopic uterine lateral suspension
Laparoscopic uterine lateral suspension for apical prolapse. Concomitant anterior and posterior colporrhaphy may be performed.
Transvaginal sacrospinous fixation
Uterus-preserving transvaginal sacrospinous fixation for apical prolapse. Concomitant anterior and posterior colporrhaphy may be performed.
Related Therapeutic Areas
Sponsors
Leads: National Cheng-Kung University Hospital

This content was sourced from clinicaltrials.gov